2. Academic Validation
  3. Calsyntenin-3 interacts with the sodium-dependent vitamin C transporter-2 to regulate vitamin C uptake

Calsyntenin-3 interacts with the sodium-dependent vitamin C transporter-2 to regulate vitamin C uptake

  • Int J Biol Macromol. 2021 Dec 1:192:1178-1184. doi: 10.1016/j.ijbiomac.2021.10.058.
Veedamali S Subramanian 1,  Trevor Teafatiller 2,  Janielle Vidal 3,  Gihan S Gunaratne 4,  Carlos J Rodriguez-Ortiz 3,  Masashi Kitazawa 3,  Jonathan S Marchant 4
Affiliations

Affiliations

  • 1 Department of Medicine, University of California, Irvine, CA 92697, United States of America. Electronic address: vsubrama@uci.edu.
  • 2 Department of Medicine, University of California, Irvine, CA 92697, United States of America.
  • 3 Department of Medicine, University of California, Irvine, CA 92697, United States of America; Department of Environmental and Occupational Health, University of California, Irvine, CA 92697, United States of America.
  • 4 Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, United States of America.
PMID: 34673103 DOI: 10.1016/j.ijbiomac.2021.10.058
Abstract

Ascorbic acid (AA) uptake in neurons occurs via a Na+-dependent carrier-mediated process mediated by the sodium-dependent vitamin C transporter-2 (SVCT2). Relatively little information is available concerning the network of interacting proteins that support human (h)SVCT2 trafficking and cell surface expression in neuronal cells. Here we identified the synaptogenic adhesion protein, calsyntenin-3 (CLSTN3) as an hSVCT2 interacting protein from yeast two-hybrid (Y2H) screening of a human adult brain cDNA library. This interaction was confirmed by co-immunoprecipitation, mammalian two-hybrid (M2H), and co-localization in human cell lines. Co-expression of hCLSTN3 with hSVCT2 in SH-SY5Y cells led to a marked increase in AA uptake. Reciprocally, siRNA targeting hCLSTN3 inhibited AA uptake. In the J20 mouse model of Alzheimer's disease (AD), mouse (m)SVCT2 and mCLSTN3 expression levels in hippocampus were decreased. Similarly, expression levels of hSVCT2 and hCLSTN3 were markedly decreased in hippocampal samples from AD patients. These findings establish CLSTN3 as a novel hSVCT2 interactor in neuronal cells with potential pathophysiological significance.

Keywords

Alzheimer's disease; CLSTN3; Interactor; SVCT2; Transport; Vitamin C.

Figures